Page last updated: 2024-10-24

busulfan and Endometrial Neoplasms

busulfan has been researched along with Endometrial Neoplasms in 1 studies

Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Research Excerpts

ExcerptRelevanceReference
"Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls."5.33Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005)
"Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls."1.33Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, M1
Watanabe, G1
Shirota, M1
Maekawa, A1
Taya, K1

Other Studies

1 other study available for busulfan and Endometrial Neoplasms

ArticleYear
Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats.
    The Journal of reproduction and development, 2005, Volume: 51, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Atrophy; Busulfan; Endometrial Neoplasms

2005